Covid-19 roundup: J&J charts swift path to 1B vaccine doses; Embassy cable spotlights possible Wuhan lab connection to coronavirus
J&J, the first large pharmaceutical company to unveil its performance in the first quarter, acknowledged the coronavirus pandemic has had …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
